NEXI YTD Return



Start date: 12/29/2023
End date: 04/18/2024
Start price/share: $2.22
End price/share: $3.30
Dividends collected/share: $0.00
NEXI YTD return: 48.65%
Annualized Gain: 161.43%
Starting investment: $10,000.00
Ending investment: $14,865.00
Years: 0.30


NEXI YTD return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare NEXI YTD return (see YTD Return Meaning) versus benchmarks:

YTD Return S&P
YTD Return Dow
YTD Return Nasdaq 100
YTD Return Russell 2000
YTD Return Gold
YTD Return 10 Year Treasury
YTD Return By Sector
YTD Return on $10,000.00
Without Dividends Reinvested Into NEXI


Also see: NEXI Average Annual Return
NexImmune is a clinical-stage biotechnology company developing an approach to immunotherapy designed to employ the body's own T cells to generate a specific immune response that mimics natural biology. Co. has two product candidates: NEXI-001 in acute myeloid leukemia, and NEXI-002 in multiple myeloma. Co.'s product candidates are adoptive T cell therapies (ACTs) that contain populations of naturally occurring CD8+ T cells that recognize a defined set of disease-relevant antigen targets. In addition to its programs using the Artificial Immune Modulation (AIM) ACT adoptive cell therapy modality, Co. is also developing an off-the-shelf injectable modality, which it refers to as AIM INJ. The NEXI YTD return is shown above.

The YTD Return on the NEXI YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis.

Thus, researching Year-To-Date Returns is good practice for investors — whether NEXI YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the NEXI YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns.
Quotes delayed 20 minutes

Email EnvelopeFree NEXI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in YTD Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
NexImmune (NEXI) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:

NGM YTD Return
NK YTD Return
NKGN YTD Return
NKTR YTD Return
NKTX YTD Return
NLNK YTD Return
NLTX YTD Return
NMRA YTD Return
NMRD YTD Return
NMTC YTD Return
More Healthcare companies »

 

NEXI YTD Return | www.YTDReturn.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in YTDReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.